Le Lézard
Classified in: Health, Business
Subjects: PDT, VEN, SBS

Advanced Nutrition Company, Healthycell, Launches Reg CF Crowdfunding Campaign on StartEngine.com


CHARLESTON, S.C., Nov. 10, 2021 /PRNewswire/ -- Healthycell today announced it launched a Regulation CF crowdfunding campaign on StartEngine.com.

This crowdfunding round comes after an oversubscribed $1.5 million Bridge Round led by Keen Growth Capital with participation from Balanced Breakfast Fund.

Healthycell is a nutrition company helping people reach their potential through optimized health. It uses patent-pending MICROGELtm technology to deliver nutrients they can absorb and results they can measure in a pill-free experience they love. Their ingestible gel dietary supplement products are taken straight from the gel pack, mixed into drinks, or blended into smoothies.

The nutrition industry company was selected as one of only 7% of applicants to Newchip's competitive accelerator program. It is currently in discussions with several major pharmacy chains and retailers nationwide to grow its B2B channel sales. The D2C channel remains strong with over 2,000 new customers acquired per month and growing, a sustainable cost per acquisition, and a strong customer lifetime value.

"We believe the future of human nutrition lies at the intersection of three core pillars: (1) Pill-free, ultra-absorption delivery systems, (2) Validation on an N=1 basis with personalized biomarker test kits, and (3) Personalization of human nutrition," commented Healthycell Founder and CEO, Douglas Giampapa. "We are working to blend all three pillars into a cohesive offering for our customers."

Visit StartEngine.com, which contains important information and disclosures, including financial statements and risk factors.                                                             

About Healthycell 

About MICROGELtm 

To learn more, visit healthycell.com, Twitter, Facebook, and Instagram.

Media Contact:
Douglas Giampapa
973-433-9585
[email protected]

SOURCE Healthycell


These press releases may also interest you

at 03:20
Qilu Pharmaceutical, one of the leading vertically integrated pharmaceutical companies in China that develops, manufactures, and distributes both finished formulations and Active Pharmaceutical Ingredients, announced that the results of the phase II...

1 déc 2022
ARCH Medical Solutions Corp. ("ARCH") has acquired Nicholas Precision Works ("NPW") of North Manchester, Indiana, the company announced today. As a contract manufacturing company specializing in precision grinding, NPW provides surgical cutting tools...

1 déc 2022
Waterdrop Inc. ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the third quarter ended...

1 déc 2022
Parnell Pharmaceuticals Holdings Ltd ("Parnell") announced its intention to raise US$4.0 million through a backstopped rights offering at no charge (the "Rights Offering") for qualifying shareholders of record as of December 6, 2022 (the "Record...

1 déc 2022
Allied Market Research recently published a report, titled, "Menstrual Cramps Treatment Market by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), by Treatment (Non-steroidal Anti-inflammatory Drugs, Hormonal Therapy), by Distribution Channel...

1 déc 2022
Jacobio Pharma (1167.HK) will present the results of KRAS G12C inhibitor JAB-21822 as a single agent or in combination with SHP2 inhibitor JAB-3312 in preclinical cancer models in a poster session during the 2022 European Society of Medical Oncology...



News published on 10 november 2021 at 08:44 and distributed by: